Meeting
2017 Genitourinary Cancers Symposium
Targeting ERBB2 mutations in urothelial carcinoma.
Authors
Francois Audenet
Memorial Sloan Kettering Cancer Center, New York, NY
Francois Audenet , Sumit Isharwal , Maria E. Arcila , Samuel Funt , Jonathan E. Rosenberg , Dean F. Bajorin , Bernard H. Bochner , Michael F. Berger , Hikmat Al-Ahmadie , David B. Solit , Gopa Iyer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Prostate Cancer,Urothelial Carcinoma,Prostate Cancer
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 354)
DOI
10.1200/JCO.2017.35.6_suppl.354
Abstract #
354
Poster Bd #
G18
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Comprehensive targeted gene profiling to determine the genomic signature likely to drive progression of high-grade nonmuscle invasive bladder cancer to muscle invasive bladder cancer.
First Author: Abedalrhman Alkhateeb
Poster
2020 ASCO Virtual Scientific Program
Targeted DNA sequencing analysis to reveal genetic diversity and androgen-receptor alteration in advanced EGFR mutant lung adenocarcinoma.
First Author: Wei Wu
Poster
2018 Genitourinary Cancers Symposium
Defining the DNA damage repair (DDR) genomic landscape of urothelial carcinoma of the bladder (UCB).
First Author: Shawn Dason
Poster
2016 ASCO Annual Meeting
Comparative molecular analyses of pancreatic cancer (PC): KRAS wild type vs. KRAS mutant tumors and primary tumors vs. distant metastases.
First Author: Mohamed E. Salem